PND40 PAYER AND SOCIETAL BENEFIT OF PEGINTERFERON BETA-1A VERSUS SUBCUTANEOUS INTERFERON BETA-1A IN PATIENTS WITH RELAPSING-REMITTING MULTIPLE SCLEROSIS IN SPAIN
Nov 1, 2019, 00:00
10.1016/j.jval.2019.09.1810
https://www.valueinhealthjournal.com/article/S1098-3015(19)34188-9/fulltext
Title :
PND40 PAYER AND SOCIETAL BENEFIT OF PEGINTERFERON BETA-1A VERSUS SUBCUTANEOUS INTERFERON BETA-1A IN PATIENTS WITH RELAPSING-REMITTING MULTIPLE SCLEROSIS IN SPAIN
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)34188-9&doi=10.1016/j.jval.2019.09.1810
First page :
Section Title :
Open access? :
No
Section Order :
11573